What is the ROCE (Return on Capital Employed) of IGC Pharma this year?
The ROCE of IGC Pharma is -1.2 undefined this year.
IGC Pharma ROCE 2024
IGC Pharma ROCE
-1.2
Ticker
IGC
ISIN
US45408X3089
WKN
A1T87A
In 2024, IGC Pharma's return on capital employed (ROCE) was -1.2, a 168.82% increase from the -0.45 ROCE in the previous year.
IGC Pharma Aktienanalyse
What does IGC Pharma do?
India Globalization Capital Inc. (IGC) is a Maryland-based company that focuses on the development, marketing, and sale of natural supplements, novel cannabis formulations, food and beverages, and the manufacturing of medical devices. IGC was established in 2005 and initially operated as a construction company in India. However, over the years, the company has evolved into a diversified company based in Maryland due to its innovative products and services. One of IGC's most well-known divisions is IGC Pharma, which focuses on cannabis-based medical formulations and medical devices. IGC holds patent applications for certain cannabis-based products and was one of the first companies to explore the use of cannabis as a potential treatment for Alzheimer's patients. In collaboration with the Institute for Medicine and the Origins of Infancy at the University of Maryland, IGC developed a novel THC-based medication for the treatment of spasms, pain, and other symptoms in multiple sclerosis patients. IGC has also developed the "Hyalolex" product, which is made from specific cannabinoids such as CBD. This preparation is available in Germany under the trade name "Cannabidiol Hexal." Hyalolex is available as a dietary supplement and has been proven effective in improving memory performance, attention, and cognitive abilities in Alzheimer's patients. IGC also operates the IGC Nutraceuticals division, which focuses on the manufacturing and marketing of high-quality natural products. These include vitamins, minerals, dietary supplements, and natural herbal supplements that promote physical and mental well-being and support healthy bodily processes. Some of IGC Nutraceuticals' products include Saffron for Depression Relief, the calcium and magnesium formulation, and Bharat Diagnostics. IGC will continue to invest in various fields, including cannabis-based pain relief, dementia treatments, electrochemical energy storage, and the manufacturing of devices that utilize natural resources such as coal and ore. Overall, IGC has become a diversified company that focuses on a variety of industries. IGC has been a pioneer in the cannabis industry and has gained a good reputation through innovative formulations and patents. By expanding into new industries and investing in new technologies, IGC will continue to stay at the forefront of innovation and strengthen its position as one of the emerging development companies in today's economy. IGC Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling IGC Pharma's Return on Capital Employed (ROCE)
IGC Pharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing IGC Pharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
IGC Pharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in IGC Pharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about IGC Pharma stock
How has the ROCE (Return on Capital Employed) of IGC Pharma developed compared to the previous year?
The ROCE of IGC Pharma has increased by 168.82% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of IGC Pharma?
A high Return on Capital Employed (ROCE) indicates that IGC Pharma has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of IGC Pharma?
A low ROCE (Return on Capital Employed) can indicate that IGC Pharma has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from IGC Pharma impact the company?
An increase in the ROCE of IGC Pharma can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of IGC Pharma affect the company?
A decrease in ROCE of IGC Pharma can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of IGC Pharma?
Some factors that can affect IGC Pharma's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of IGC Pharma so important for investors?
The ROCE of IGC Pharma is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can IGC Pharma take to improve the ROCE?
To improve the ROCE, IGC Pharma can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does IGC Pharma pay?
Over the past 12 months, IGC Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IGC Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of IGC Pharma?
The current dividend yield of IGC Pharma is .
When does IGC Pharma pay dividends?
IGC Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IGC Pharma?
IGC Pharma paid dividends every year for the past 0 years.
What is the dividend of IGC Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IGC Pharma located?
IGC Pharma is assigned to the 'Industry' sector.
Wann musste ich die Aktien von IGC Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IGC Pharma from 9/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.
When did IGC Pharma pay the last dividend?
The last dividend was paid out on 9/24/2024.
What was the dividend of IGC Pharma in the year 2023?
In the year 2023, IGC Pharma distributed 0 USD as dividends.
In which currency does IGC Pharma pay out the dividend?
The dividends of IGC Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The IGC Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von IGC Pharma
Our stock analysis for IGC Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IGC Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
